Verantos has received a grant from the National Science Foundation (NSF) to conduct research and development on real-world evidence (RWE) outcomes. This cooperative agreement will enable accurate identification of clinical outcomes from routinely collected data to further advance RWE. The two-year study will leverage artificial intelligence and data from heterogeneous sources.
“The NSF is known for supporting innovative, cutting-edge ideas that have the potential to make huge societal impacts,” said Dan Riskin, MD, CEO of Verantos and Principal Investigator on the grant. “This award reflects the great need in the healthcare industry to understand outcomes in real-world settings to better tailor therapy for future patients.”
Recommended AI News: Sumo Logic and AWS Collaborate to Transform Security for Multi-Cloud and Hybrid Threat Protection
Widely considered the market leader in high-accuracy RWE generation, Verantos offers a platform that leverages artificial intelligence and advanced data sources to generate RWE capable of supporting clinical assertions. As pharmaceutical firms increasingly look to RWE to support clinical, regulatory, and payer decision-making, high-validity evidence and accurate identification of clinical outcomes are a critical part of all studies.
“NSF is proud to support technologies of the future by thinking beyond incremental developments and funding the most creative, impactful ideas across all markets and areas of science and engineering,” said Andrea Belz, Division Director of the Division of Industrial Innovation and Partnerships at NSF. “With the support of our research funds, any deep technology startup or small business can guide basic science into meaningful solutions that address tremendous needs.”
Recommended AI News: HFS Ranks Accenture the No. 1 Provider for ServiceNow Services
Support for this new cooperative agreement is provided by the National Science Foundation’s Small Business Innovation Research Program, under Award Number 2024958. The grant follows Verantos’ successful completion of feasibility research under a separate NSF award.
Recommended AI News: M2Catalyst and HERE Partner to Improve the Mobile Network Experience
Comments are closed.